---
title: Improve balance through eye exercises
nct_id: NCT07525973
phase: NA
status: RECRUITING
sponsor: Pardis Specialized Wellness Institute
study_type: INTERVENTIONAL
canonical_url: "https://parkinsonspathways.com/trial/NCT07525973"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT07525973"
last_fetched: "2026-06-13T14:07:46.236Z"
source: "Parkinson's Pathways (curated)"
---
# Improve balance through eye exercises

**Goal (in five words):** Improve balance through eye exercises

**Official Title:** The Effect of Eye Exercises on Physical Function, Balance, and Fall Risk in Patients With Parkinson's Disease: A Randomized Controlled Trial

**Trial ID:** [NCT07525973](https://clinicaltrials.gov/study/NCT07525973)

## Key Facts

- **Phase:** NA
- **Status:** RECRUITING
- **Study Type:** INTERVENTIONAL
- **Sponsor:** Pardis Specialized Wellness Institute
- **Target Enrollment:** 34 participants
- **Start Date:** 2026-05-01
- **Completion Date:** 2026-09-01
- **Conditions:** Parkinson Disease
- **Interventions:** Supervised In-Center Eye Exercises
- **Intervention Types:** BEHAVIORAL

## Summary For Families

They want to see if guided eye exercises can improve physical function, steadiness, and lower fall risk by helping the eyes and brain better guide balance and stepping. The treatment is supervised in-center eye exercises that train gaze stability, visual tracking, and visual-motor coordination so your eyes, head, and body work together more smoothly; it is non-drug and does not change levodopa or other Parkinson meds, participants just need to be on a stable regimen. Looking for adults 18 to 80 with idiopathic Parkinson's at Hoehn and Yahr stages 1 to 3 who can stand and walk (with or without a device) and attend sessions. People with severe cognitive or visual impairment, unstable heart or other acute medical problems, or changing Parkinson medications are excluded.

## What This Actually Involves

**Placebo** _(From the protocol)_: This trial has a group that receives no study treatment (you would continue your usual care) alongside the treatment group. Because assignment is random, you have about a 1 in 2 chance (roughly 50%) of being in the no-treatment group, assuming the groups are filled equally. Ask the coordinator to confirm the exact assignment ratio.

**Visits** _(From the protocol)_: You will attend supervised in-center sessions lasting approximately 30 to 45 minutes, 3 sessions per week for 8 weeks.
  > "Each session will last approximately 30 to 45 minutes, 3 sessions per week for 8 weeks."

**Procedures** _(Ask the coordinator)_: Ask the coordinator what tests and procedures are involved, for example blood draws, scans, or questionnaires, and whether any are uncomfortable or invasive.

**Washout** _(Ask the coordinator)_: Ask the coordinator whether you would need to stop or pause any of your current medications before or during the study (a washout period), and for how long.

**Travel & reimbursement** _(Ask the coordinator)_: Ask the coordinator whether travel, parking, or your time is reimbursed or compensated, and what is covered.

_Fields marked “From the protocol” come from the trial's registry record or quoted protocol text. Fields marked “Ask the coordinator” are not reliably available and should be confirmed directly._

## Eligibility

- **Minimum age:** 18 Years
- **Maximum age:** 80 Years
- **Sex:** ALL

### Full Criteria

```
Inclusion Criteria:

Aged 18 years and older Clinically diagnosed idiopathic Parkinson's disease Hoehn and Yahr stage 1-3 Stable antiparkinsonian medication regimen Able to stand unaided and walk with or without an assistive device Able to provide written informed consent Able to attend supervised in-center exercise sessions Able to follow simple exercise instructions

Exclusion Criteria:

Severe cognitive impairment Unstable cardiovascular, orthopedic, or neurologic conditions that interfere with safe participation Active infection or acute medical illness Hemodynamic instability Severe visual impairment or other sensory impairment that prevents participation Recent myocardial infarction or stroke Unstable or changing antiparkinsonian medication regimen Any other condition that, in the judgment of the study physician, makes participation unsafe
```

## Locations (1)

- Pardis specialized wellness institute, Isfahan, Iran _(32.6525, 51.6746)_
  - Nasrin Salimian — (CONTACT) — +98 913 205 1202 — statisrin@gmail.com

## Central Contacts

- Nasrin Salimian — (CONTACT) — +989132-51202 — statisrin@gmail.com
- Mohammad Ali Tabibi, Dr — (CONTACT) — +989133184624 — m.tabibi@ut.ac.ir

---

*Canonical: https://parkinsonspathways.com/trial/NCT07525973*  
*HTML version: https://parkinsonspathways.com/trial/NCT07525973*  
*Source data: https://clinicaltrials.gov/study/NCT07525973*